- 3.9Impact Factor
- 6.8CiteScore
- 18 daysTime to First Decision
Special Issues
Sustainability publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process.
The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue polices and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.
Recent Advances in Endothelial Dysfunction
Deadline: 31 March 2026
Advances in Oral Squamous Cell Carcinoma Research
Deadline: 31 March 2026
Skin Diseases and Cell Therapy
Deadline: 31 March 2026
Medicinal Cannabis: Advances in Therapeutics and Clinical Applications
Deadline: 31 March 2026
New Advances in the Pathology, Diagnosis and Treatment of Thyroid Tumors
Deadline: 31 March 2026
Advanced Research in Thyroid and Parathyroid Diseases
Deadline: 31 March 2026
Next-Generation Nanoparticles: Innovations in Biomedical Applications and Theranostics
Deadline: 31 March 2026
New Approaches to Spinal Cord-Related Diseases
Deadline: 31 March 2026
Emerging Trends and Applications in Nanomedicine and Targeted Therapies
Deadline: 31 March 2026
Fibromyalgia and Neuroinflammation: Unraveling Pathophysiological Links and Therapeutic Targets
Deadline: 31 March 2026
Emerging Trends in Liver Diseases and Cirrhosis Research
Deadline: 31 March 2026
Imaging and Modeling Alzheimer's Disease: The Quest for Mechanistic Understanding, Early Diagnosis, and Novel Treatments
Deadline: 31 March 2026
of 149

